Podcasts about aids

During our continued news hour on NightSide, we discussed a new report from Congress that has raised the alarm about children with mental health conditions being held in juvenile detention, rather than getting treatment…8:05PM: A new report from Congress has raised the alarm about children with mental health conditions being held in juvenile detention, rather than getting treatment…A discussion about the lack of mental health services for children.Guest: Tim Murphy, PhD - licensed psychologist8:15PM: Discovering King Tut’s Tomb, a comprehensive show about the monumental discovery of the celebrated Egyptian Boy King, opens on February 28 at the Saunders Castle at Park Plaza.Guest: Mark Lach - expert spokesperson for the exhibition of Discovering King Tut’s Tomb 8:30PM: Addressing the virulent anti-Semitism that has bizarrely found a home at Harvard and MIT…Guest: David Nabhan (pronounced how it sounds Nab – Han) - science columnist for the Times of Israel 8:45PM: Shooting Up: A Memoir of Love, Loss and Addiction. The child of missionary parents thrusted into Madrid, Spain’s San Blas neighborhood tells the story of a unique childhood among heroin addicts during the AIDS epidemic. A haunting exploration of belief, belonging, and the profound costs—and rewards—of sacrifice.Guest: Jonathan Tepper – Author of this book. Grew up in Madrid in the 1980s, and his parents started a drug rehab among heroin addicts. – He is currently the chief investment officer at Prevatt CapitalSee omnystudio.com/listener for privacy information.

Matthew Bannister onMartyn Butler who was a central figure in the UK's early response to HIV and AIDS. He was a co-founder of the Terrence Higgins Trust and gave his own home phone number as a helpline.Allan Massie, the Scottish author and critic whose hero was Sir Walter Scott. Sir Ian Rankin pays tribute. Professor Nicola Fear, the epidemiologist who studied the effects on military personnel of serving in the Iraq War and Afghanistan.Willie Colón, the American trombonist who was inspired by his Puerto Rican heritage to create salsa music.Interviewee: Tony Whitehead Interviewee: Sir Ian Rankin Interviewee: Professor Sir Simon Wessely Interviewee: Garth CartwrightProducer: Gareth Nelson-Davies Assistant Producer: Ribika Moktan Editor: Glyn TansleyArchive used: Martyn Butler seminar recording, Terrence Higgins Trust, THT YouTube channel, uploaded 26/06/2022; Terrence Higgins Trust actuality recording, Week In Week Out, BBC Wales, 29/10/1985; News report, BBC News, 08/01/1987; Advert: Iceberg, Department of Health and Social Security, Dir Nicolas Roeg, Voiceover: John Hurt, 1987; Allan Massie, The Book Programme: First Novels, BBC Two, 11/02/1978; Allan Massie interview, France Politics, Writers Revealed, BBC Radio 4, 06/07/1992; Allan Massie interview, General Election Report, BBC News, 10/04/1997; Nicola Fear, The Fear Factor: life as a military epidemiologist, King's College London, uploaded to YouTube on 23/04/2018; Iraq War news report, BBC News, 31/03/2009; Afghanistan News Report, BBC News, 27/10/2014; Willie Colon interview, Latin Music USA, BBC Four, 05/02/2010;

In this episode of Infinite Loops, we sit down with author Jonathan Tepper to discuss his extraordinary childhood. In 1985, when Jonathan was seven, his missionary parents moved the family to San Blas — then the heroin capital of Europe — to start a drug rehabilitation center. Jonathan and his brothers grew up alongside former bank robbers, prison survivors, and people living through the AIDS epidemic. These recovering addicts became like older siblings to them. What began with one man in a small apartment grew into a global movement operating in 20 countries. Jonathan's memoir, Shooting Up: A Memoir of Love, Loss, and Addiction, is out now and published in the US by Infinite Books and in the UK by Little, Brown Book Group. Important Links Buy Shooting Up: A Memoir of Love, Loss and Addiction: https://www.infinitebooks.com/books/products/shooting-up Read the first chapter for free: https://infiniteloops.substack.com/p/give-them-to-anyone-who-looks-like Learn more about Jonathan here: https://jonathan-tepper.com/

In this episode of Money Tales, our guest is Stephanie Ellis-Smith. Marriage caused Stephanie to face two hard truths at once. The medical career she had poured herself into did not fit the life she wanted to build with her husband. And perhaps even more unsettling, a career in medicine was not clicking the way she had always assumed it would. When she stepped away, Stephanie felt like she was walking out on an identity her family had invested everything in. Her dad even told her, quite bluntly, that she had no employable skills. Then, in the middle of that uncertainty, Stephanie said yes to a small volunteer opportunity. That single yes ended up rerouting her life into a decades long career in philanthropy, including founding three nonprofits and Phila Engaged Giving. Stephanie is the CEO and founder of Phīla Engaged Giving, a philanthropic advisory firm established in 2017 that works with donors who are ready to activate their assets for social change. As an advisor and social impact specialist, she works toward a world where philanthropy is a nurturing and equity-centered practice that connects wealth to the people and communities who need it most. Stephanie is a Chartered Advisor in Philanthropy (CAP®) with extensive experience in advising high-impact individuals and companies. She believes strongly in being a compassionate and generous member of society and brings nearly 30 years of professional and personal life experience in governance, family wealth and nonprofit leadership to the social sector. In the wake of the racial uprisings of 2020, she co-founded Giving Gap, an online database to help donors find and support Black-founded and led organizations in their communities. Having served in a variety of professional capacities—non-profit CEO, social enterprise COO, foundation and non-profit trustee and corporate board member—Stephanie's extensive background and deep knowledge makes her uniquely well-positioned to be a trusted advisor to the world's most generous families and institutions. Stephanie's expertise in navigating wealth, impactful generosity and civic engagement is frequently sought by leading philanthropic institutions and mainstream publications and she has frequently appeared as a keynote speaker at major social sector convenings. Several Seattle mayors and former Washington Governor Gary Locke have appointed Stephanie to serve on a variety of boards and public commissions. She is currently a member of the Seattle Art Museum's Museum Development Authority Board and the board of the National Center for Family Philanthropy. She was appointed a Dean of Philanthropy in 2022 by The Purposeful Planning Institute. Stephanie has BA degrees from UCLA in both English Literature and Biochemistry. Given her keen interest in science, Stephanie's post-graduate years were spent in university labs working on stem cell and AIDS-related research. She has two adult children and lives in Seattle with her husband, the historian Douglas Smith. Finding Purpose Through Philanthropy Stephanie's journey shows that philanthropy is far more than writing checks or serving on boards. It is a deeply human practice that shapes relationships, careers and how we understand money, power and purpose. From her own career pivot to the way she helps families navigate charitable giving, her story illustrates how generosity can change the giver as much as the causes they support. By speaking openly about her own money story, identity and career reinvention, she reminds listeners that meaningful giving begins with honest conversations and a willingness to learn. If you are thinking about how to align your wealth with your values, an Aspiriant advisor can help you clarify your purpose, structure your giving and build a thoughtful philanthropic plan that fits your family. Follow Money Tales on Spotify, Apple Podcasts or YouTube Music for more real stories that help us make smarter, more intentional decisions with our money.

Dr. Cary L. Goodman has a sincere passion to empower faith communities to operate at their fullest capacity in areas of health promotion, advocacy programs, outreach and development. For over 18 years, he has been dedicated to establishing and expanding health programs across the United States by building the capacity to address health disparities that greatly impact congregations and the communities they serve by strategically leveraging faith-based and community partnership to impact sustainability. Currently, Cary serves as the Faith Based Program & Engagement Consultant for The Balm In Gilead, Inc. where he works diligently at the intersection of faith and public health nationally to address the burden of various diseases the impact African American communities. A highly skilled strategist and national speaker adept at leading relationship building and engagement opportunities, he has forged various faith based and public health community partnerships and coalitions. An ordained minister, Cary deems himself a “connector” where he focuses on the significance of outreach and engagement, establishing coalitions, collaborating, and relationship building in order to increase accessibility and sustainability to strengthen congregations and communities.

Africa Melane chats to SANAC’s Nelson Dlamini about treasury allocating R26bn to provinces to sustain HIV/AIDS treatment. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Send a FanMail to the GenX Stories gang via text message!It's time. The Gen X Stories crew gets brutally honest about growing up in the shadow of AIDS panic, whispering about Dr Ruth after dark, and parents who absolutely did not have “The Talk” with us. We dig into how we pieced together our own sex education through rumors, paperbacks, health class scare tactics, and sheer survival,. You may recognize the funny (and sometimes unpleasant) experiences that followed, and why buying condoms felt like applying for federal clearance. PLUS we are open about flipping the script on how we're talking about sex with our own kids now. (Spoiler: less fear, more facts.) It's awkward. It's cathartic. It might make you text your therapist. But hey — at least we can finally talk about it. (although maybe not with our moms...)Episode linksWhy the Sex Talk with Kids Is a Myth (And What Works Better)History of Sex Education in the USHow AIDS Changed the History of Sex EducationThe History Behind Judy Blume's Most Controversial Novel, ForeverWhen Dr. Ruth Doled Out ‘80s-Era Sex AdviceRisky Busness Movie Train Scene“Where Did I Come From?” book“What's Happening to me?” book- Girls edition“What's Happening to me?” book- Boys edition“This is so awkwzrd: modern puberty explained” bookConnect with usSubscribe to GenX St

In this episode, produced in partnership with RahrBSG, we're taking a close look at process aids in the brewhouse and cellar, from anti-foaming agents and finings to enzymes and more. Whether you're trying to keep more foam in your beer (rather than lose it while brewing and cellaring), fill tanks with more beer and less headspace (by limiting foam height within tanks), or clarify beer while reducing filtering time and expense (by using finings), there's a process aid that fits your goal. Here, we discuss the ins and outs of using these tools effectively in the brewery with Sam Pecoraro of Von Ebert in Portland, Oregon; Steve Theoharides of Zero Gravity in Burlington, Vermont; and Ashton Lewis, technical support manager at RahrBSG. We produced this episode in partnership with RahrBSG, your leading source for brewing ingredients and supplies. To learn more about the solutions RahrBSG offers, visit their site and contact your representative today.

Stephen Shames – A Legendary Documentary Photographer (Part 2)

People often take the easy path, but what can you achieve and grow by jumping into thorny problems that don't have an obvious solution?Today's guest on Contrary to Ordinary is Dr. Alex Vieira. He's a pioneer in cleft-palate research, has authored more than 400 scientific papers, and is the most cited expert in the field.In this episode, Alex shares his journey from growing up in Rio de Janeiro during the military regime to becoming a leading figure in oral health research. He discusses his decision to pursue dentistry, influenced by an admired uncle, the challenges of starting his research career during the AIDS epidemic, and his fascination with the Human Genome Project.In this episode's commentary, Kim discusses the importance of the entrepreneurial mindset and the roles of genetics and environment in shaping human behavior. He emphasizes the value of collaboration, the importance of local contributions to global impact, and the need to maintain high research standards. Overall, Alex believes in following one's passion and making meaningful changes in the immediate environment, which he sees as having a trickle-down effect on broader societal improvements.Episode Highlights01:49 –Alex's early life.04:41 – How working with genetics changed the trajectory of Alex's career.08:00 – Kim's thoughts: Surround yourself with those you admire - the rest will follow.08:46 – The Human Genome Project and dentistry.12:10 – The road less travelled and the genetics of extraordinary.14:47 –Kim's thoughts: Can you change your genetic predisposition through forming new habits?15:55 – The complicated world of genetics and dental caries.19:49 – What drives Alex?20:41 – Kim's thoughts: The entrepreneurial mindset isn't just for business people.23:43 –How does Alex maintain a high standard of work?24:47 – What's next for Alex?25:56 – Alex's final thoughts.ResourcesFollow your curiosity, connect, and join our ever-growing community of extraordinary minds.CariFree WebsiteCariFree on InstagramCariFree on FacebookCariFree on PinterestDr. Alex Vieira BioThe Human Genome Project WebsiteThe Power of Habit - Charles DuhiggAtomic Habits: An Easy & Proven Way to Build Good Habits & Break Bad Ones - James Clear

With Australia on track to be among the first countries in the world to eliminate the transmission of HIV, there is a lot to be optimistic about. Yet globally the rates of transmission and AIDS-related deaths are predicted to rise, disproportionately impacting marginalised communities and people living in low and middle income countries.   Weakening US political commitment and recent funding cuts are threatening the delicate global healthcare architecture designed to prevent and treat HIV/AIDS. High-income countries, like Australia, have a crucial role to play in enabling accessible research, testing, treatment, healthcare and public education with international communities.  Hear renowned leading infectious disease researcher and President of the International AIDS Society, Dr Beatriz Grinsztejn, in conversation with Australia’s Dr Norman Swan. From diversifying funding sources to strengthening universal public health systems and promoting community involvement, Dr Grinsztejn and Dr Swan will discuss how to overcome the setbacks deepening the inequities between who gets care and who goes without. Co-presented by the UNSW Centre for Ideas, Kirby Institute and UNSW Medicine & Health.See omnystudio.com/listener for privacy information.

Annie thought about running a marathon for nearly ten years before finally lining up at the Chicago Marathon in 2025. After withdrawing from the race the year before due to injury, she rebuilt from the ground up, committed to strength training, and found something even bigger than a finish time through Team to End AIDS. What started as a comeback became a summer of long runs on the lakefront, new friendships, and learning how to run smart instead of just hard.In this episode, Annie shares how Peloton helped her actually learn the fundamentals of running, what it looked like to navigate injury and depression, and how she executed a negative split on her first marathon by trusting her training. We talk race day nerves, hometown crowds, chocolate chip bagels with peanut butter, and why treating your training like rehearsal might be the mindset shift every runner needs. Follow along with the show: 

IM (19/11/1957 – 23/2/2000) – Ofra Haza is Dood maar niet vergeten. De Israëlische zangeres is bekend van Im Nin'alu en haar deelname aan het Eurovisie Songfestival met Chai in 1983. Zij overleed vandaag in 2000…Continue Reading "Israëlisch cultureel boegbeeld stierf aan aids"

Gregory Zuckerman introduces the brilliant, driven scientists pursuing vaccines for AIDS, cancer, and malaria, who pivoted their controversial methodologies to confront the burgeoning COVID-19 pandemic. 3

To Find All Things StrangeBrew!---> linktr.ee/strangebrewpodcastSign up for our Patreon go to-> Patreon.com/cultofconspiracypodcastMeta Mysteries Podcast---> https://open.spotify.com/show/6IshwF6qc2iuqz3WTPz9Wv?si=3a32c8f730b34e79Cajun Knight Youtube Channel---> https://www.youtube.com/@Cajunknighthttps://flavorsforest.com/cult/Become a supporter of this podcast: https://www.spreaker.com/podcast/cult-of-conspiracy--5700337/support.

Show Notes: Rick Thomas interviews Jonathan Tepper, the author of Shooting Up: A Memoir of Love, Loss, and Addiction, a coming-of-age memoir set in Madrid's San Blas neighborhood during Spain's heroin and AIDS crisis. Raised by missionary parents who founded a drug rehabilitation center at the height of the epidemic, Tepper tells a gritty, lyrical story of addiction, recovery, faith, and loss, as seen through the eyes of an American boy growing up in the middle of it. Watch or Listen: https://lifeovercoffee.com/podcast/ep-568-jonathan-tepper-shooting-up-a-memoir-of-love-loss-and-addiction/ Will you help us to continue providing free content for everyone? You can become a supporting member here https://lifeovercoffee.com/join/, or you can make a one-time or recurring donation here https://lifeovercoffee.com/donate/.

Two-Time NY Times Bestselling AuthorFrom her own remarkable experiences, Janet created the profoundly impactful Passion Test process. This simple, yet effective process has transformed thousands of lives all over the world and is the basis of the NY Times bestseller she co-authored with Chris Attwood, The Passion Test: The Effortless Path to Discovering Your Life Purpose & Shine Your Light: Powerful Practices for an Extraordinary Life by Janet Bray Attwood and Marci Shimoff .Janet is a living example of what it means to live a passionate, fully engaged life. A celebrated transformational leader, Janet has shared the stage with people like His Holiness the Dalai Lama, Sir Richard Branson, Nobel Prize winner, F.W. deKlerk, Stephen Covey, Jack Canfield, and many others. She is also known as one of the top marketers in America. In 2000, Mark Victor Hansen and Robert G. Allen paid for 40 of the top marketing experts in the country to come to Newport Beach, CA to consult with them on marketing their book, The One Minute Millionaire. Janet was one of the very first they invited. As a result of that meeting, Robert G. Allen and Mark Victor Hansen asked Janet to partner with them in their Enlightened Millionaire Program. Her personal stories of following her passions, of the transformations which people like Chicken Soup for the Soul author Jack Canfield have experienced with The Passion Test, and the practical, simple exercises she takes people through to discover their own passions are a few of the reasons she gets standing ovations wherever she presents. Janet has given hundreds of presentations and taken thousands of people through The Passion Test process,in the U.S., Canada, India, Nepal, and Europe. Janet is also the founder of The Passion Test for Business, The Passion Test for Coaches, The Passion Test for Kids and Teens, The Passion Test for Kids in lockdown, and The Reclaim Your Power program for the homeless. Janet is a golden connector. She has always had the gift of connecting with people, no matter what their status or position. From the influential and powerful, to the rich and famous, to lepers and AIDS patients, to the Saints of India, Nepal, the Philippines and elsewhere—to anyone who is seeking to live their destiny, Janet bonds with every single person, and the stories she shares are inspiring, mind-boggling, uplifting and very real. A co-founder of top online transformational magazine, Healthy Wealthy nWise, Janet has interviewed some of the most successful people in the world about the role of passion in living a fulfilling life. Her guests have included Stephen Covey, Denis Waitley, Robert Kiyosaki, Neale Donald Walsch, Paula Abdul, Director David Lynch, Richard Paul Evans, Barbara DeAngelis, marketing guru Jay Abraham, singer Willie Nelson, Byron Katie, Wayne Dyer, Nobel Prize winner Muhammad Yunus, Tony Robbins, Rhonda Byrne and many others. These live teleconference interviews have attracted listeners from all parts of the globe Janet and Chris are both founding members of that organization whose 100+ members serve over 25 million people in the self-development world. Janet Attwood makes magic happen. Her presentations hold audiences spellbound. Her programs attract people from all over the globe. Through her magnetic charisma she is touching the lives of millions of people around the world. janetattwood.com'© 2026 All Rights Reserved© 2026 Building Abundant Success!!Join Me on ~ iHeart Media @ https://tinyurl.com/iHeartBASSpot Me on Spotify: https://tinyurl.com/yxuy23baAmazon Music ~ https://tinyurl.com/AmzBAS https://tinyurl.com/BASAud

GS#488 May 12, 2015  Martin Chuck, the inventor of the hugely successful Tour Striker returns to showcase his newest products and actually convinces host Fred Greene that there are training aids that can be as valuable as lessons and a lot more cost effective! Martin gives a full description of his hot new "Smart Ball" which assists in avoiding the chicken wing that makes your back arm fly out on the backswing. Martin is actually surpirsed and flattered to find out that it's being used by players on the PGA Tour,. We also discuss his two latest inventions and recap his hugely successful Tour Striker. Martin's closing tip explains why you slice the ball and how to fix it. This tip is also a video available at http://YouTube.com/GolfSmarterTV http://TourStriker.comIf you have a question about whether or not Fred is using any of the methods, equipment or apps we've discussed, or if you'd like to share a comment about what you've heard in this or any other episode, please write because Fred will get back to you. Either write to golfsmarterpodcast@gmail.com or click on the Hey Fred button, at golfsmarter.com

What if the biggest threat to your prostate health isn't your PSA, but the slow drift into inflammation, fatigue, and metabolic chaos that nobody warns you about? Today, Dr. Geo is joined by Dr. Ronald Hoffman, one of America's most respected voices in integrative medicine and host of the Intelligent Medicine podcast. With nearly 40 years of continuous broadcasting and clinical practice, Dr. Hoffman shares his "diversified portfolio" for aging successfully.What You'll Learn:✅ The "Mirror" Effect: Discover why your prostate is a reflection of your whole system—including hormones, blood sugar, stress, and cardiovascular health.✅ The #1 Longevity Driver: Why "purpose" and having a trajectory are more important than any supplement for preventing biological entropy.✅ Dr. Hoffman's Supplement Protocol: Insights into the essential role of Vitamin D, Omega-3s, and advanced mitochondrial support like Urolithin A and NAD.✅ Evolving Your Exercise: Why "no pain, no gain" fails as you age and how to prioritize your "hinges" (joints) to avoid injury.✅ A 40-Year Clinical Perspective: Lessons learned from the front lines of New York medicine, from the early AIDS epidemic to working alongside Dr. Atkins.Episode Highlights:00:00 Is your PSA the most important metric? 02:40 Standing on the shoulders of giants: The history of health radio in NYC. 10:45 Epigenetics: How environment pulls the trigger on your genetic "gun." 14:30 Dr. Hoffman's turning point from a "cerebral nerd" to a triathlete. 33:50 Key takeaways for reducing the risk of chronic disease. 38:00 The "Top 3" supplements for men's health and longevity. 48:30 Why joint health (the "hinges") is more critical than muscle mass alone. 53:20 Rethinking "training to failure" for men over 60About Dr. Ronald Hoffman: Dr. Hoffman is the host of the Intelligent Medicine podcast and has been a leading voice in natural healthcare since 1988. He shares his experience working alongside luminaries like Dr. Atkins and his transition from conventional internal medicine to a diversified "portfolio" of health. https://drhoffman.com/___________________________________

There are a seemingly infinite number of training aids out there. Where do you start? What training aid helps with which issues? LKD breaks down some of his favorites, how they work and who they're for in Episode 2 of the miniseries 'Training aids I like.' Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

It took years for U.S. leaders to address the AIDS epidemic of the 1980s. One public figure that wasn't afraid to bring the challenges the LGBTQ+ community were facing to the forefront was the Rev. Jesse Jackson. In the Loop reflects on Jackson's work pushing progressive ideas and being an avid supporter of the LGBTQ+ community with Northwestern professor Martha Biondi and Equality Illinois CEO Channyn Lynne Parker. For a full archive of In the Loop interviews, head over to wbez.org/intheloop.

In this episode of Reading With Your Kids, we first head to 1990s New York City with Broadway actor and author Andrew Keenan-Bolger, here to celebrate his YA novel Limelight. Set in 1996, the story follows Danny, a shy Staten Island teen who lands a spot at LaGuardia High School, the famed performing arts school. Andrew explains that Danny is not a version of his younger, confident, Broadway‑kid self; instead, he wanted to write about someone with their "nose pressed to the glass," feeling like an outsider looking in—just like so many real teens do. Andrew talks about moving to New York as a child actor, the sensory overload of Times Square in the 90s, and how that era's gritty, transforming city—along with the evolving realities of queer life post–AIDS crisis—shaped this queer coming‑of‑age story. He leans into the darkness of the period: toxic masculinity, homophobia, racism, and misogyny, while still keeping the book tender and often funny. Theater deeply informs his writing—his sense of rhythm, character, and ensemble—and writing Limelight alone gave him a new sense of confidence and purpose. He also dreams of adapting the book for TV or film someday. Later in the episode, we travel to Hartford, Connecticut, to meet Devon Torres, author‑illustrator of the rhyming picture book Freddy the Frog. Devon shares how Freddy's playful, confident energy is meant to remind families of unstructured playground fun in a screen‑saturated world. Drawing on his love of art, support from his wife, and inspiration from teachers, Devon hopes the Friendables series will blend vibrant illustrations, joyful play, and gentle learning for young readers.

"American culture likes martyrs, not marchers." — David Masciotra, quoting Jesse JacksonA couple of days ago, a great American died. Jesse Jackson was 84. He was somebody. Even Donald Trump acknowledged the passing of "a good man"—which, as my guest today notes, Jackson probably wouldn't have appreciated. David Masciotra is the author of I Am Somebody: Why Jesse Jackson Matters, one of the most readable biographies of the African-American leader. Having spent six years covering him and more than 100 hours in conversation, he called Jackson a friend.Masciotra borrows from Jackson on Americans preferring martyrs to marchers. It's easy to celebrate him now that he's gone. But when Jesse was being Jesse—battling economic apartheid, registering millions of voters, building a Rainbow Coalition—he had many critics and enemies, including some of those hypocrites now praising him.Jackson's legacy is vast. After King's death, he focused on economic justice, securing thousands of jobs for Black workers and entrepreneurs. He ran for President twice, nearly winning the 1988 nomination. He pushed for proportional delegate allocation—without which Obama would never have won in 2008. He debated David Duke and, in Masciotra's words, "reduced him to a sputtering mess." He was the first presidential candidate to fully support gay rights. He slept beside gay men dying of AIDS in hospices. He marched with Latino immigrants from California into Mexico.But perhaps most relevant today: Jackson showed how to build a coalition that transcended racial politics without ignoring race. "If we leave the racial battleground to find economic common ground," MLK's spiritual successor insisted, "we can reach for moral higher ground." That's the populist strategy Masciotra believes the Democrats need now—a vision, he fears, trapped between the identitarian politics of its left and the milquetoast neoliberalism of its right flank. Five Takeaways●      Martyrs, Not Marchers: American culture celebrates civil rights leaders after they're dead. When Jackson was hard at it, he had enemies—including some now praising him.●      Jackson Made Obama Possible: Jackson pushed for proportional delegate allocation. Without it, Obama—who won small states—would never have beaten Clinton in 2008.●      Jackson Debated David Duke: And reduced him to a sputtering mess. Duke's response: "Jackson's intelligence isn't typical of Blacks." Jackson believed refusing debate only empowers enemies.●      Race and Class Are Linked: Jackson showed you can't substitute race for class or use race to erase class. Leave the racial battleground for economic common ground.●      Visionaries Win the Marathon: Jackson often lost the sprint but won the marathon. His Rainbow Coalition vision is what Democrats need now—and keep fumbling. About the GuestDavid Masciotra is a cultural critic, journalist, and author of I Am Somebody: Why Jesse Jackson Matters. He spent six years covering Jackson and more than 100 hours in conversation with him. He is an old friend of Keen on America.ReferencesPeople mentioned:●      Martin Luther King Jr. was Jackson's mentor. Jackson was an aide to King and was with him on the balcony the day he was assassinated.●      David Duke, former KKK leader, debated Jackson in 1988. Jackson wiped the floor with him.●      W.E.B. Du Bois and Booker T. Washington represent a historic dichotomy in Black political thought. Jackson occupied space between positions.●      Rosa Parks was eulogized by Jackson, who noted that she succeeded simply because "she was available."●      Robert Kennedy shared Jackson's universal vision of coalition-building across racial lines.Organizations mentioned:●      Operation PUSH was Jackson's organization focused on economic justice for Black Americans.●      The Rainbow Coalition was Jackson's political movement seeking to unite Americans across race and class.Further reading:●      Masciotra's UnHerd piece: "Jesse Jackson Transcended America's Racial Politics"About Keen On AmericaNobody asks more awkward questions than the Anglo-American writer and filmmaker Andrew Keen. In Keen On America, Andrew brings his pointed Transatlantic wit to making sense of the United States—hosting daily interviews about the history and future of this now venerable Republic. With nearly 2,800 episodes since the show launched on TechCrunch in 2010, Keen On America is the most prolific intellectual interview show in the history of podcasting.WebsiteSubstackYouTubeApple PodcastsSpotify Chapters:(00:00) - Introduction: A great man died (01:14) - Martyrs, not marchers (02:49) - Jackson in the context of King (05:07) - The Booker T.–Du Bois dichotomy (08:14) - Did Jackson make Obama possible? (11:15) - The marathon, not the sprint (13:25) - How a white guy from Chicago became Jackson's biographer (16:32) - Jackson vs. David Duke (20:43) - I Am Somebody: the origin (24:06) - Transcending racial politics (30:26) - The Rainbow Coalition as progressive populism (33:23) - What Jackson teaches us about leadership (36:26) - Will Jackson be remembered?  

Join me in welcoming word witch, Kate Belew, to the pod!Kate Belew is an author, poet, and Witch. Her work exists at the crossroads of creativity and magic. She has taught and facilitated circles and workshops worldwide since 2017. She is dedicated to the spirit of poetry, the sacred wild of the planet, and seeks enchantment in all she does. She is a forever student of the plants and the stars. She has an MFA in Poetry from Sarah Lawrence College and is an initiated Green Witch. Her roots are in Michigan, and her wings are in Brooklyn, two places she calls home. Here is the link to her website, where you can find her book as well as how to work with her. The whole website is pasted below as well.https://katebelew.com/Post- Episode Correction: I stated that the author of a quote was a black queer activist. I was incorrect in that this was a queer activist, but they are not black. Here is the quote from Dan Savage, speaking on resilience during the AIDS crisis: "We buried our friends in the morning, we protested in the afternoon, and we danced all night."Link to "Gravy" poem by Raymond Carver hereThanks for listening! Leave a comment if you enjoyed today's episode

Venha visitar a nossa Loja:https://iconografia-da-historia-3.myshopify.com/?utm_medium=product_shelf&utm_source=youtubeSiga nosso canal de CORTES:https://www.youtube.com/@IconografiadaHistoria-cortesE siga também nosso canal parceiro "CAFÉ E CAOS TV" apresentado pelo nosso querido Fernandão e Agnes Andradehttps://www.youtube.com/@CafeecaostvAJUDE-NOS A MANTER O CANAL ICONOGRAFIA DA HISTÓRIA: Considere apoiar nosso trabalho, participar de sorteios e garantir acesso ao nosso grupo de Whatsapp exclusivo: https://bit.ly/apoiaoidhSe preferir, faz um PIX: https://bit.ly/PIXidhNos acompanhe no Spotify @iconocastSiga ICONOGRAFIA DA HISTÓRIA em todas as redes: https://linktr.ee/iconografiadahistoriaoficialSiga o JOEL PAVIOTTI: https://bit.ly/joelpaviottiApresentação: Joel PaviottiTexto e roteirização: Adriana de PaulaRevisão: Adriana de PaulaCâmera e produção: Fernando ZenerattoEdição: Fernando ZenerattoDireção: Fernando Zeneratto / Joel Paviotti

David Zellnik tells Kevin Allison about a moment of sexual liberation in a dark back room at a gay bar in the early 90s. Check out all of our Conversation Stories!

Welcome to Art is Awesome, the show where we talk with an artist or art worker with a connection to the San Francisco Bay Area. Today, Emily features San Francisco wire sculptor Kristine Mays discussing her politically charged exhibition "State of the Union" at Modernism Gallery. Created in response to the uncertainty and division at the beginning of 2025, the show explores themes of American identity, social justice, and individual responsibility through intricate wire sculptures.Kristine walks through several powerful pieces: "This is America," a frayed wire American flag with beads representing blood and tears; "Human Complacency," depicting the see/hear/speak no evil concept; and "Modern Day Lynchings and Hashtag Memorials," featuring hand-embroidered names of Black people killed by police on silk ribbons. Many works incorporate quotes from writers like Audre Lord, whose words "your silence will not save you" inspired Mays to create this body of work as both political statement and personal healing.She traces her creative journey from childhood craft projects with her mother to her current practice working with construction-grade wire. She explains how she creates faceless figures and sculptural garments that allow viewers to project their own stories and recognize loved ones through gesture alone. The meditative quality of working with wire and its durability appeal to her desire to create lasting legacy work.A major milestone: the Smithsonian National Museum of African American History and Culture recently acquired her piece "Hush Harbor." Kristine, who has participated in San Francisco Open Studios for over 20 years, credits her "divinely led" journey and her mother's early encouragement to create without fear of failure.About Artist Kristine Mays :Kristine Mays, a San Francisco native has been an exhibiting artist since 1993. She was the Grand Finale Winner in 2015 of the 5th Annual Bombay Sapphire Artisan Series National Competition. This competition not only provided an opportunity to exhibit her work at Art Basel Miami, but she had a solo exhibition at the Scope NYC Art Fair as well, and was also afforded a chance to collaborate on a large scale public mural. Her mural is on the side of the Boom Boom Room in San Francisco on Fillmore and Geary Streets. (It has large wire feathers placed among the portraits that adorn the walls, reflecting the fleeting existence of black jazz musicians in San Francisco.) In 2015 she also participated in the Hearts in San Francisco program, creating a large 400 pound heart for their annual public art installation. The heart spent a few weeks on display in Union Square before going to its final home upon purchase from AT&T.In 2009, Kristine was a featured artist in the San Francisco Art Commission's "Art in Storefronts" pilot program, a project which transformed vacant storefronts and commercial corridors into a destination for contemporary art, bringing a new energy to the Bayview Hunters Point neighborhood. A participant in the San Francisco Open Studios program for over 20 years, Kristine has also served on the Board of Directors for ArtSpan-- the Producers of SF Open Studios and has participated on several of their committees. Kristine served as the 2011-2013 artist-in-residence at the Bayview Hunters Point Shipyard in San Francisco. She is a graduate of Lowell High School, received her Bachelor Degree in Arts Administration from DePaul University and has occasionally served as a grant review panelist through the San Francisco Arts Commission.Seeking to create impact and change with her art, Kristine has participated in raising thousands of dollars for AIDS research through the sale of her work by collaborating with organizations like Visual Aid, the San Francisco Alliance Health Project and WE-Actx. Her work has received local and national press including mentions in the San Francisco Chronicle, New York Times, The New York Post, The Washington Post, Source Magazine, Artsy, and the interior design blog Apartment Therapy. She is represented by Simon Breitbard Fine Arts in SF, the Richard Beavers Gallery in Brooklyn and Zenith Gallery in Washington DC.Kristine has participated in programming at the De Young Museum, Museum of African Diaspora (MoAD) and exhibited at the California African American Museum (CAAM) in Los Angeles, CA. Collectors of her work include an eclectic mix of people including Star Wars creator George Lucas and the dearly departed Peggy Cooper Cafritz (who amassed one of the country's largest private collections of African-American art). Her work is displayed in many Bay Area homes and private collections throughout the USA.Visit Kristine's Website:  KristineMays.comFollow Kristine on Instagram: @KristineMaysFor more about Kristine's exhibit, "State of the Union" CLICK HERE--About Podcast Host Emily Wilson:Emily a writer in San Francisco, with work in outlets including Hyperallergic, Artforum, 48 Hills, the Daily Beast, California Magazine, Latino USA, and Women's Media Center. She often writes about the arts. For years, she taught adults getting their high school diplomas at City College of San Francisco.Follow Emily on Instagram: @PureEWilFollow Art Is Awesome on Instagram: @ArtIsAwesome_Podcast--CREDITS:Art Is Awesome is Hosted, Created & Executive Produced by Emily Wilson. Theme Music "Loopster" Courtesy of Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 LicenseThe Podcast is Co-Produced, Developed & Edited by Charlene Goto of @GoToProductions. For more info, visit Go-ToProductions.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode: Republican leaders in the Florida Legislature unveil new state budgets with big funding gaps over everything from affordable housing and AIDS medication to a new baseball stadium for the Tampa Bay Rays. At the same time, the state House wants to impose serious spending guardrails and transparency rules on Gov. Ron DeSantis. The Florida Senate does not. Plus: New College of Florida, money sink. An update from Day 35 of Florida's 2026 legislative session.Show notesThe bill's discussed in today's show: House Bill 5001 — General Appropriations ActPassed the House Budget Committee by 26-1 vote (vote sheet)Senate Bill 2500 — AppropriationsHouse Bill 5503 — Trust Funds/Re-creation/Emergency Preparedness and Response Fund/EOGPassed the House Transportation & Economic Development Subcommittee by a 12-0 vote (vote sheet)House Bill 5601 — Higher EducationPassed the House Higher Education Budget Subcommittee by a 9-4 vote (vote sheet)House Bill 437 — Public RecordsPassed the House Justice Budget Subcommittee by a 13-0 vote (vote sheet)The stories discussed in today's show: Buried in the budget: Mike Huckabee, Donald Trump and NewsmaxCorporations could get a $3.5 billion tax break in Florida unless state lawmakers step in to stop itFlorida DOGE Details Disproportionate Spending at New CollegeFinding more room for New College is a state priority, USF board chair saysQuestions or comments? Send ‘em to Garcia.JasonR@gmail.comListen to the show: Apple | SpotifyWatch the show: YouTube Get full access to Seeking Rents at jasongarcia.substack.com/subscribe

Many people mistakenly believe that the AIDS and HIV crises are over. Nothing is further from the truth. AIDS Foundation Chicago continues to provide care and housing assistance for so many Chicagoans who may struggle to make ends meet while they continue their battle against HIV. It is true that medications are better and more […]

For this Out Takes, we had a stack of reviews to cover some of the films on offer in cinemas and online this February. We started off by saying bon retour to the 37th Alliance Française French Film Festival which kicks off again across Australia from March 3rd. One of the queer highlights in this year’s program is ‘The Little Sister’ which tells the story of Fatima (played by Nadia Melliti), who is the youngest daughter of a Franco-Algerian family living in the suburbs of Paris. Surrounded by her sisters, she grows up in a warm, loving household shaped by strong traditions and Muslim faith. A gifted student, she graduates high school and enrols in a philosophy program in Paris, where she is suddenly exposed to a world far removed from everything she knows. In the capital, new encounters and ideas unsettle her certainties, specifically her exploration of her sexuality and connection with the queer community. This beautiful film was selected for the Official Competition at the 2025 Cannes Film Festival, where Nadia Melliti won the Best Actress award and the film received the Queer Palm and is a must-see. We then took a look at ‘Cashing Out’, a new documentary that is streaming now online for free from The New Yorker that tells a little heard story about an insurance scheme that had a huge impact in the early years of the AIDS epidemic in the U.S. ‘Cashing Out’ was shortlisted for this year's Best Documentary Short Film and was executive produced by Matt Bomer and RuPaul's Drag Race alumni Angeria Paris Van Michaels and is another incredible story of the resilience of our community in the face of an epidemic. We then moved on to ‘Wuthering Heights’, the latest film from celebrated writer and director Emerald Fennell who brought together Margot Robbie, Jacob Elordi and a Charli XCX soundtrack for her ‘horny’ interpretation of the classic novel by Emily Bronte. Everyone has a lot to say about this new version, so we jumped on the bandwagon to give you the Out Takes take on this one. We ended the program by spotlighting ‘She’s The He’, the closing night film at this year’s Mardi Gras Film festival, plus we paid tribute to two wonderful talents and LGBTQ allies, Catherine O’Hara and James Van Der Beek, who both sadly passed away recently. The post The Little Sister, Cashing Out and Wuthering Heights appeared first on Out Takes.

SEASON 4 EPISODE 59: COUNTDOWN WITH KEITH OLBERMANN A-Block (2:30) SPECIAL COMMENT: Just because we're paranoid, that doesn't mean Trump isn't out to get us. Trump has just accidentally revealed crucial details of his conspiracy to steal the midterms. It starts with the cadaver-in-chief, demanding of active troops at Fort Bragg – “you have to vote for us” – that’s in case the Generals or even the Joint Chiefs realize Mark Kelly is right: they HAVE to disobey illegal orders, ESPECIALLY Trump’s illegal orders. If it came to that, Trump would have the raw troops overthrow the generals And then Trump succubus Kristi Noem vowed to make sure Trump only lets the RIGHT people voting, electing the RIGHT leaders. And he’s already had ICE PRACTICE voter suppression – murder of civilians – in Minnesota. How do we stop Trump? Talk about it endlessly. Talk about his attempt to make the troops loyal to HIM and not the constitution. Talk about his attempts to seize ballots. Talk about his attempt to use ICE to intimidate voters. Talk about it, now, now, now. Trump is plotting to steal the midterms. We not only CAN stop him - we have to. MEANWHILE, HOW MUCH MORE CAN THE MEDIA BETRAY US? Jake Tapper - as guilty as anybody in the business of putting his salary ahead of all journalism - tells us to hang in there? An old boss of mine says something stupid. CBS decides to platform Stephen A. Smith, the Jill Stein of 2026. B-Block (55:00) THE WORST PERSONS IN THE WORLD: What happened to Congressman Randy Fine demanding the arrest of everybody who enjoyed Bad Bunny's Swear-filled Super Bowl Show? The White House doesn't know how to spell "cue." And enjoying the Olympics? It's all crap - especially what it did to the history of the Olympics and the National Hockey League. C-Block (1:25:00) THINGS I PROMISED NOT TO TELL: More media criticism. This disaster didn't start yesterday. By 2004, when an anchor on MSNBC told one of his viewers - live on the air - to "get AIDS and die" - and his boss said he had to be fired for that, his boss's boss (THE PRESIDENT OF NBC) tried to intervene to save his job. See omnystudio.com/listener for privacy information.

Guest: Patrick K. O'Donnell. A failed Union raid on Richmond carrying orders to kill Jefferson Davis prompts the Confederacy to escalate irregular warfare and political influence operations. As the Confederate Secret Service aids the Copperhead movement, author Herman Melville embeds with Union cavalry to witness the hunt for the elusive John Mosby1880 GAR PICNIC MN

On November 24, 1991, Freddie Mercury — the electrifying frontman of Queen whose operatic voice and theatrical brilliance redefined rock stardom — died at the age of 45 from complications related to AIDS, just one day after publicly confirming his diagnosis. With towering anthems like Bohemian Rhapsody, We Are the Champions, Somebody to Love, and We Will Rock You, Mercury helped transform Queen into one of the most innovative and globally beloved bands in music history, blending hard rock, glam, opera, and pop into something entirely their own. His four-octave vocal range, magnetic stage presence, and fearless individuality shattered conventions and expanded what a rock performer could be. His death, coming at a time when the AIDS crisis was still shrouded in stigma and silence, marked the end of one of music's most extraordinary voices — but cemented a legacy that continues to echo across generations. Hosts: Jason Beckerman & Derek Kaufman Learn more about your ad choices. Visit podcastchoices.com/adchoices

Series: N/AService: Radio Program / PodcastType: Radio Program / PodcastSpeaker: E.R. Hall, Jr.

Series: N/AService: Radio Program / PodcastType: Radio Program / PodcastSpeaker: E.R. Hall, Jr.

Area 51 Insider Phil Schneider, an American patriot, exposes the war he fought at a secret base in New Mexico. Phil breaks down the shootout he got into with some cops and aliens. It seems like he's on some sort of FBI watch list and repeatedly threatens to kill his enemies. His fingers are blown off, AIDS came from aliens, and he hates Janet Reno.If you enjoyed the show, please Like & Subscribe to our channel and share the links. This show can be found @hiddeninplainsightradio on Instagram and @thehiddenpod on Twitter.iTunes Link: https://podcasts.apple.com/us/podcast/hidden-in-plain-sight/id1488538144?i=1000459997594Spotify Link: https://open.spotify.com/episode/5zsntvl63Do7m9gNTD8Za2?si=MczvbuMlRuCbmWChclVUZAYouTube Link: https://www.youtube.com/channel/UCNRejWJs0hn8pefj5FiE7ZQRumble Link: https://rumble.com/c/c-389525If you want to support the show, check out our Patreon: https://www.patreon.com/hiddeninplainsightpod

There are a seemingly infinite number of training aids out there. Where do you start? What training aid helps with which issues? LKD breaks down some of his favorites, how they work and who they're for in this new miniseries Training aids I like. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Unaids e Fundação Alemã, Das, apelaram a mais parcerias e financiamento para sustentar a ações contra o vírus nas duas regiões; novas infeções e mortes relacionadas com a Aids continuam a aumentar.

Co-Host Lisa Arch joins us with our guest, Stan Zimmerman.From a supportive teacher who first recognized his talent to writing some of television's most beloved episodes, Stan Zimmerman's journey is a testament to passion, persistence, and perfect timing.He sets it all out in his new book 'The Girls: From Golden to Gilmore,' which draws from journals he has kept religiously since college, offering a deeply personal look at a life lived inside television history. In a conversation both heartfelt and hilarious, Stan reflects on how he took school theater as seriously as if it were big time show biz, because to him, it was. Theater kids were his tribe, and storytelling was already his calling.That destiny led him to Hollywood, where in his early 20s, at meeting that had not gone well, on his way out the door, he pitched a Hail Mary Golden Girls story idea that launched his career. The episode he co-wrote with his writing partner, Jim Berg is titled “Blanche and the Younger Man.” It earned the team a Writers Guild nomination and carved the trailhead for a groundbreaking career path.  Working in the 1980s during the height of the AIDS crisis, Stan recalls how even in Hollywood many people were still in the closet, and that while building career relationships, on a show that would become a gay obsession, he felt pressure to hide his personal life. We also hear stories that could only happen in show business: hanging out with Sandra Bernhard when an answering machine message from Madonna sparked the beginning of their friendship; witnessing Estelle Getty struggle with early-onset dementia on set, and later realizing that Betty White's jokes to the studio audience, which he thought were at Estelle's expense, may have been acts of quiet kindness, allowing Estelle space to recover her lines.Stan reflects on the enduring legacy of The Golden Girls, a show whose cultural impact he couldn't have imagined while he was in the writers' room. He talks about passing on season one of Roseanne because of a five-year contract commitment, only to later campaign to join the writing staff. (The story behind the “13” on his shirt traces back to that turbulent chapter of his career.) He explains how Roseanne was never about chasing laughs, a lesson that became clear when he later helped develop a Russian adaptation where producers kept asking why it wasn't funnier.Stan also discusses his longtime friendship with Dan and Amy Sherman-Palladino and how creative circles overlap in surprising ways that found him on the team creating episodes of The Gilmore Girls. And he shares a moving story about working on a Dreamgirls benefit show which almost derailed over stewing conflicts until Stan suggested that Sheryl Lee Ralph, Loretta Devine and Jennifer Holiday just talk, on stage, about their shared history… Suddenly, they were singing. Stan's stories will inspire you to problem solve, dream and achieve. In recommendations --Lisa: The Later Daters on NetlflixWeezy: Take That miniseries on NetflixPath Points of InterestStan ZimmermanThe Girls: From Golden To Gilmore by Stan ZimmermanStan Zimmerman on IMDBStan Zimmerman on WikipediaStan Zimmerman on FacebookStan Zimmerman on InstagramGolden Girls: The Ultimate Fan ExperienceMedia Path Interview with Michael FishmanLater DatersTake That  Documentary Series

A very special Progressive Commentary Hour as Gary Null pays tribute to Peter Duesberg. The Progressive Commentary Hour presents Part 1 of the Gary Null documentary 'Deconstructing the Myth of Aids' 

In episode 67 of Going anti-Viral, Dr Martin Hirsch joins host Dr Michael Saag to discuss his career in HIV medicine, mentorship, and his scientific legacy. Dr Hirsch is a Professor Emeritus at Harvard Medical School and was Director of the Harvard Collaborative AIDS Treatment Evaluation Unit from 1986 to 2003 and Director of the Harvard Multidisciplinary AIDS Research Training Grant. Dr Hirsch's research focused on finding drug combinations that delay the development of multidrug resistance and reduce viral replication in HIV-1 infection. Dr Hirsch served as an Editorial Board member for numerous prestigious medical journals over the past 3 decades, including AIDS, the New England Journal of Medicine, Clinical Infectious Diseases, and the Journal of Infectious Diseases, where he was Editor-in-Chief. Dr Hirsch discusses his extensive career, the evolution of antiviral therapies, and the importance of mentorship in science. He reflects on his early experiences, the emergence of HIV, and the collaborative efforts that led to advancements in treatment. Dr Hirsch emphasizes the need for individualized mentorship and shares insights on the future of HIV research and his optimism for the potential of HIV prophylactic treatments.0:00 – Introduction1:50 – Early career and mentorship5:07 – Transitioning to HIV research7:55 – The emergence of antiretroviral therapies11:06 – The AIDS epidemic and initial cases14:30 – Collaboration in HIV research17:42 – The AZT trial and its impact20:16 – Navigating the shift from CMV to HIV22:39 – Antiretroviral resistance and combination therapy26:39 – The role of mentorship in science30:56 – Future directions in HIV researchResources:Going-anti-Viral: Episode 6 - A Conversation With Dr Anthony Fauci __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Die Zerschlagung von USAID war ein Schock. Auch für viele HIV-infizierte Menschen in Uganda. Viele lokale Hilfskräfte wurden entlassen. Das einst erfolgreiche HIV-Programm steht auf der Kippe. Können die Menschen in Uganda selbst die Lücke füllen? Von Bettina Rühl www.deutschlandfunkkultur.de, Feature

“Even though we say we want to be self-sufficient, we don't think global solidarity must be dropped. Because if it gets dropped, the world will be in trouble.”Mayeni Jones the BBC's Africa correspondent speaks to Dr Aaron Motsoaledi South Africa's health minister a year on since the US announced foreign aid cuts. At the time he called the USAID freeze a wake up call for Africa. Dr Motsoaledi, has been at the centre of South Africa's public health response for more than a decade. A medical doctor by training, he first took on the health portfolio in 2009, overseeing the world's largest HIV treatment programme.In this conversation he explains how the country is filling the aid gap and where progress stands in the fight against HIV and AIDS. The Interview brings you conversations with people shaping our world, from all over the world. The best interviews from the BBC, including episodes with Syria's only female cabinet minister, Hind Kabawat, Ugandan human rights lawyer Nicholas Opiyo and Mexican actor, Diego Calva. You can listen on the BBC World Service on Mondays, Wednesdays and Fridays at 0800 GMT. Or you can listen to The Interview as a podcast, out three times a week on BBC Sounds or wherever you get your podcasts. Presenter: Mayeni Jones Producers: Ed Habershon, Farhana Haider Editor: Justine LangGet in touch with us on email TheInterview@bbc.co.uk and use the hashtag #TheInterviewBBC on social media.(Image: Dr Aaron Motsoaledi Credit: PHILL MAGAKOE/AFP via Getty Images)

Veronique de Rugy of the Mercatus Center argues that while Trump's deregulation aids growth, erratic tariffs and government industrial subsidies create uncertainty, functioning effectively as taxes that hinder the economy.1859 FIVE POINTS

🧭 REBEL Rundown 📌 Key Points 💨 HFNC met criteria for non-inferiority to BPAP for preventing intubation or death within 7 days in four of the five ARF subgroups.🧪 Bayesian dynamic borrowing increased power across subgroups but created variable certainty, especially in smaller groups such as COPD.🫁 The immunocompromised hypoxemia subgroup did not meet non-inferiority, leading to early trial stopping for futility.️ Rescue BPAP use, subgroup-specific exclusion criteria, and non-standardized BPAP delivery are important contextual factors that influence how subgroup results should be interpreted. Click here for Direct Download of the Podcast. 📝 Introduction Bilevel Positive Airway Pressure (BPAP) has long been a foundational modality in the management of acute respiratory failure (ARF), particularly in COPD exacerbations and cardiogenic pulmonary edema, where it can rapidly reduce work of breathing and improve gas exchange. It remains a core tool in our respiratory support arsenal.High-flow nasal cannula (HFNC), however, has expanded what we can offer patients by delivering many of the same physiologic benefits through a far more comfortable interface. With high flows, modest PEEP, and effective dead-space washout, HFNC can improve oxygenation and decrease work of breathing while preserving the ability to talk, cough, eat, and interact with staff and family. This combination of physiologic support and tolerability makes HFNC especially attractive in patients where comfort, anxiety, or cardiovascular stability are key considerations, and in settings where prolonged noninvasive support may be needed. Rather than competing with BPAP, HFNC broadens our options in ARF and allows us to better match the modality to the patient and their underlying disease process.The RENOVATE trial set out to answer a high-impact question across five distinct etiologic groups: Is HFNC non-inferior to BPAP (NIV) for preventing intubation or death in acute respiratory failure? 🧾 Paper Azoulay É, et al. High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial. JAMA. 2025 PMID: 39657981 🔙Previously Covered On REBEL: HFNC: Part 1 – How It WorksHFNC: Part 2 – Adult and Pediatric IndicationsFLORALI and AVOID TrialFLORALI-2: NIV vs HFNC as Pre-Oxygenation Prior to IntubationThe Pre-AeRATE Trial – HFNC vs NC for RSI ️ What They Did CLINICAL QUESTION Is HFNC non-inferior to BPAP for rate of endotracheal intubation or death at 7 days in patients with acute respiratory failure due to a variety of causes? STUDY DESIGN Multicenter, randomized non-inferiority trial33 Brazilian hospitalsNov 2019 – Nov 2023Adaptive Bayesian hierarchical modeling with dynamic borrowingOpen label, outcome adjudicators blindedPatients were classified into 5 subgroups SUBGROUPS 1. Non-immunocompromised hypoxemiaSpO₂ < 90% on room air orPaO₂ < 60 mm Hg on room air plusIncreased respiratory effort (accessory muscle use, paradoxical breathing, thoracoabdominal asynchrony) orRespiratory rate > 25 breaths/min2. Immunocompromised hypoxemiaDefined as:Use of immunosuppressive drugs for >3 monthsOR high-dose steroids >0.5 mg/kg/dayOR solid organ transplantOR solid tumors or hematologic malignancies (past 5 years)OR HIV with AIDS / primary immunodeficiency3. COPD exacerbation with acidosisHigh clinical suspicion of COPD as primary diagnosisRR >25 with accessory muscle use, paradoxical breathing, and/or thoracoabdominal asynchronyABG: pH 454. Acute cardiogenic pulmonary edema (ACPE)Sudden onset dyspnea and rales± S3 heart soundNo evidence of aspiration, infection, or pulmonary fibrosisCXR consistent with pulmonary edema5. Hypoxemic COVID-19 (added June 2023)Added due to deviations between expected and observed outcome proportionsAny patient across the other 4 groups with PCR-confirmed SARS-CoV-2 infection in any of the above groups POPULATION Inclusion Criteria:≥18 yrs with ARF* in one of 5 pre-defined subgroups excluding COPD was defined by the following:Hypoxemia with SpO₂

In this episode, we sit down with Pastor Raphael Mnkandhla, Lead Pastor of City Church in Williamsport, PA, to hear the remarkable story of how God met him in profound loss and shaped him into a resilient shepherd. From growing up in Zimbabwe and working in AIDS-awareness ministry to navigating trauma, grief, and pastoral leadership, Raphael shares how suffering has deepened his compassion, clarified his calling, and refined his inner life. Together, we explore the paradox of grief and joy in ministry, the subtle idols and ruling passions pastors must confront, and the practices that sustain hope over the long haul. This conversation offers honest encouragement for pastors and leaders who long to lead from a healed and wholehearted place.Pastor Raphael's BioListen to Raphael's Podcast: Fueled Pastoral ResilienceTo contact: raphael@citychurchpa.orgOn Social Media: https://twitter.com/rafmnkhttps://www.facebook.com/mkristuhttps://instagram.com/rafmnk/Dave's book: The Spiritually Healthy LeaderPrecious Remedies Against Satan's Devices

Cher's confused as Gary Graff breaks down the Grammy Awards, Today Show Savannah Guthrie's missing mom mystery, R. Kelly's urine victim writes memoir, more Epstein revelations, and Kim Kardashian finds new dong. Trudi is BACK with a new robotic shoulder. Drew met some dude named after Oakland/LA/Las Vegas Raiders great Rich Gannon. He's also mad at rounding up. It's Super Bowl week! The event is going to be politically charged. Kid Rock will be headlining the TPUSA Halftime Show. We'll see if Bad Bunny speaks any English. Why is ICE showing up to the big game and the Olympics? The NFL is playing at least 7 international games this year. Gary Graff joins the show to break down the 2026 Grammy Awards. 2026 Grammys: Chappell Roan wore nothing. Billie Eilish made a political statement. Lady Gaga spoke up for women in the studio. Jelly Roll praised Jesus. DJ Gesaffelstein wore blackface. Cher struggled on stage. Miley Cyrus showed up with her “teenage” boyfriend. The girl R. Kelly victimized with his urine is spilling in a new book. Somebody abducted Savannah Guthrie's mother. Drew suspects her brother is to blame… based on one photo. Ryan Seacrest looks like he's on AIDS. A missing boy from Madison Heights was found safely in a neighbor's bathtub. Race car driver Lewis Hamilton the latest to dunk it in Kim Kardashian. He's the 33rd penis on her Who's Dated Who. Kanye and North West performed a boring show together in Mexico City. Super Bowl commercials are leaking left and right. Kendall Jenner is in a stinker of an ad. The latest leak of the Epstein files drops a lot of famous names. The Clintons caved and will testify before the House. Peter Attia is having a bad day, as he's fired from his brand new job on CBS News. Bill Gates allegedly gave Melinda an STD. We're still shocked the Melania film was somewhat a success. Merch can still be purchased. Click here to see what we have to offer for a limited time. If you'd like to help support the show… consider subscribing to our YouTube Channel, Facebook, Instagram and Twitter (Drew Lane, Marc Fellhauer, Trudi Daniels, Jim Bentley and BranDon)

Sarah is all hot and bothered for the "gay hockey show," Heated Rivalry, and she explains why lesbians would enjoy male on male heat. Susie is all wound up about something totally different: umbrellas. To each their own. We learn about a practice that was created in the 1980s where people dying of AIDS would sell their life insurance policies to investors, and we debate the ethics of betting on someone's death. We discuss the difference in written communication between women and men, and the reason women have to track their punctuation and balance perceived warmth and competence. We find out which celebrities are mentioned the most in pop songs, and the three factors that can increase your chances of being name dropped. Plus, Susie shares big news in the true crime world, where two of the biggest unsolved cases in history have been solved--and the same person (allegedly) did both.Brain Candy Podcast Website - https://thebraincandypodcast.com/Brain Candy Podcast Book Recommendations - https://thebraincandypodcast.com/books/Brain Candy Podcast Merchandise - https://thebraincandypodcast.com/candy-store/Brain Candy Podcast Candy Club - https://thebraincandypodcast.com/product/candy-club/Brain Candy Podcast Sponsor Codes - https://thebraincandypodcast.com/support-us/Brain Candy Podcast Social Media & Platforms:Brain Candy Podcast LIVE Interactive Trivia Nights - https://www.youtube.com/@BrainCandyPodcast/streamsBrain Candy Podcast Instagram: https://www.instagram.com/braincandypodcastHost Susie Meister Instagram: https://www.instagram.com/susiemeisterHost Sarah Rice Instagram: https://www.instagram.com/imsarahriceBrain Candy Podcast on X: https://www.x.com/braincandypodBrain Candy Podcast Patreon: https://www.patreon.com/braincandy (JOIN FREE - TONS OF REALITY TV CONTENT)Brain Candy Podcast Sponsors, partnerships, & Products that we love:Go to https://thrivecausemetics.com/braincandy for an exclusive offer of 20% off your first order.Get $10 off your first month's subscription and free shipping when you go to https://nutrafol.com and enter the promo code BRAINCANDYHead to https://cozyearth.com and use my code BRAINCANDYBOGO to get these pj's for you and someone you love! See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Leila Philip at the Hubbard Brook watershed discusses how beavers act as a keystone species that aids environmental recovery, challenging the necessity of lethal culling given modern non-lethal management options. She notes that beaver complexes actually increase trout and salmon populations and provide millions of dollars in free ecosystem engineering services.1892